Skip to main content
logo
Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
46.00
-2.00 (-4.17%)
At close: Jul 29, 2026

Pet Pharm Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
222.03222.03130.7117.8775.74
Revenue Growth
39.62%69.88%10.89%55.62%-
Gross Profit
116.44116.4469.9664.5935.86
Operating Income
14.7414.748.117.59-4.84
Net Income
24.9924.9914.519.15-3.81
Earnings Per Share
0.450.450.350.30-0.16
EPS Growth
12.22%28.44%17.07%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
518.86518.86387.93168.4916.76
Total Debt
106.16106.16143.8848.242.52
Net Cash (Debt)
412.7412.7244.05120.29-25.77
Net Cash Growth
3.78%69.11%102.89%--
Net Cash Per Share
7.547.545.903.99-1.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
34.334.328.8820.75-17.83
Capital Expenditures
-29.51-29.51-188.4-12.68-10.04
Free Cash Flow
4.794.79-159.518.08-27.87
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
52.44%52.44%53.53%54.80%47.34%
Operating Margin
6.64%6.64%6.21%6.44%-6.39%
Pretax Margin
10.89%10.89%9.50%7.76%-5.03%
Profit Margin
11.25%11.25%11.10%7.76%-5.03%
FCF Margin
2.16%2.16%-122.05%6.85%-36.80%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJul '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.2460.2460.0890.194
Dividend Per Share Growth
183.61%177.68%-54.37%-
Dividend Yield
0.51%0.36%0.23%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
101.50143.47114.14--
P/FCF Ratio
557.99748.49---
PS Ratio
12.0416.1412.67--